Exploring how Novartis' MS therapy Kesimpta balances treatment efficacy with infection risk through long-term safety data and clinical evidence.
Exploring treatment decisions for follicular lymphoma patients with high SUV measurements on PET scans, comparing R-CHOP vs R-bendamustine regimens.
How a humble published correction is a sign of science's greatest strength, not its weakness.
Discover how human epithelial cells are revolutionizing HPV vaccine production through virus-like particle technology
Explore how NCBI's comprehensive databases and tools are transforming biological research and clinical applications through interconnected data resources.
Exploring the promising results of phase 2 clinical trial of LCL161, a novel SMAC mimetic for intermediate to high-risk myelofibrosis patients.
Explore the bullish sentiment in cancer biotech investments, covering precision medicine, immunotherapy, market growth, and recent FDA approvals.
Discover how agroforestry integrates trees into farming to reduce deforestation, sequester carbon, and improve farmer livelihoods while fighting climate change.
Discover how a genetically engineered cyanobacterium produces a unique carbohydrate polymer with promising anticancer properties, and how chemical modification enhances its therapeutic potential.
Explore the therapeutic potential of cyclotetrapeptides - compact ring-shaped molecules showing promise in treating cancer, infections, and more through recent scientific breakthroughs.